Back to Search Start Over

In Q2 earnings, Charles River Laboratories reports dip in revenue and demand.

Authors :
Incorvaia, Darren
Source :
FierceBiotech; 8/7/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Demand for the company's services is likely to continue its downward trajectory through the rest of the year, according to an August 7 release. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
BUSINESS revenue
LABORATORIES

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
178912404

Tools

Authors Abstract Subjects Details